Isovue-370 76% Inj, 50ml
Overview
What is this medicine?
How to Use This Medicine
To ensure safe and effective use, take this medication exactly as directed by your doctor. Carefully read all the information provided to you and follow the instructions closely.
Before receiving this medication, it is essential to be properly hydrated. Consult with your doctor to determine if you need to drink additional fluids before administration.
After receiving this medication, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake. In some cases, other medications may be administered before this drug to help minimize potential side effects.
Storage and Disposal
This injection will be administered in a healthcare setting, and you will not need to store it at home.
Missed Dose
Since this medication is given in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication as scheduled.
Lifestyle & Tips
- Drink plenty of fluids before and after the procedure, especially if you have kidney problems, to help flush the dye out of your body.
- Inform your doctor about all medications you are taking, especially for diabetes (like metformin) or kidney problems.
- Inform your doctor about any allergies, especially to iodine or previous contrast dyes.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:
Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be fatal.
Kidney problems: Inability to pass urine, changes in urine output, blood in the urine, or significant weight gain.
Thyroid problems: Weight changes, feeling nervous, excitable, restless, or weak, hair thinning, depression, eye or neck swelling, difficulty focusing, trouble with heat or cold, menstrual changes, shakiness, or sweating.
Cardiovascular issues: Chest pain or pressure, rapid heartbeat, or abnormal heartbeat.
Severe dizziness or fainting: Sudden dizziness or loss of consciousness.
Respiratory problems: Shortness of breath.
Blood clots or circulatory issues: Swelling, warmth, numbness, color changes, or pain in a leg or arm.
Neurological problems: Weakness on one side of the body, trouble speaking or thinking, balance changes, drooping on one side of the face, or blurred vision.
Severe skin reactions: These can occur anywhere from 1 hour to several weeks after receiving the medication and may include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. Symptoms may include red, swollen, blistered, or peeling skin; red or irritated eyes; sores in the mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.
Additional Side Effects of Spinal Injection:
Seizures
Back pain
Stiff neck
Abnormal burning, numbness, or tingling sensations
Other Side Effects:
Most people do not experience significant side effects, but some may occur. If you are bothered by any of the following side effects or if they persist, contact your doctor:
Spinal injection: Headache, upset stomach, vomiting, muscle pain
* Other injection products: Feeling of warmth, hot flashes, upset stomach
Reporting Side Effects:
This is not an exhaustive list of potential side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Difficulty breathing, wheezing, or tightness in the chest
- Hives, rash, or severe itching
- Swelling of the face, lips, tongue, or throat
- Dizziness or lightheadedness
- Sudden weakness or feeling faint
- Severe pain, swelling, or redness at the injection site
- Nausea or vomiting that is severe or persistent
Before Using This Medicine
It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:
Allergies: If you are allergic to this medication, any of its components, or other substances, including foods and drugs. Describe the allergic reaction and its symptoms.
Dehydration and electrolyte imbalance: If you are dehydrated, have been eating poorly, or have recently used laxatives or diuretics.
Homocystinuria: If you have been diagnosed with this health condition.
Previous skin reactions: If you have experienced a skin reaction to this medication or similar drugs in the past.
Concurrent medications: If you are taking metformin or any other medications that may interact with this drug.
Additional Considerations for Injection Administration (Intrathecal):
Infections: If you have an active infection, inform your doctor before receiving the injection.
Seizure risk: If you are taking medications that may increase the risk of seizures or have taken such medications within the last 48 hours. Consult your doctor or pharmacist if you are unsure about potential interactions.
To ensure your safety, it is crucial to disclose all of the following to your doctor and pharmacist:
All prescription and over-the-counter medications
Natural products and vitamins
Existing health problems
Verify that it is safe to take this medication with your current medications and health conditions. Do not initiate, discontinue, or adjust the dosage of any medication without consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This is crucial because this drug can increase the risk of blood clots when used in conjunction with certain procedures, which may lead to potentially life-threatening conditions such as heart attack and stroke. If you have any questions or concerns, discuss them with your doctor.
To minimize the risk of tissue damage, it is vital to monitor the injection site for any signs of redness, burning, pain, swelling, blisters, skin sores, or fluid leakage. Immediately notify your nurse if you experience any of these symptoms, as they can indicate that the drug is leaking from the vein.
Regular blood tests may be necessary to monitor your condition while taking this medication. Consult with your doctor to determine the best course of action. Additionally, this drug may interfere with certain laboratory tests, so it is crucial to inform all your healthcare providers and lab personnel that you are taking this medication.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Pregnant or breastfeeding women, or those planning to become pregnant, should discuss the potential benefits and risks of this medication with their doctor.
Special Considerations for Children
When administering this medication to children, exercise caution, as the risk of side effects may be higher in certain pediatric patients. Children under the age of 3 may be at risk of developing low thyroid function, which can impact their development. Your child's doctor may recommend regular thyroid function tests after the injection to monitor for any potential issues. If you have any questions or concerns, consult with your child's doctor.
Overdose Information
Overdose Symptoms:
- Fluid overload (pulmonary edema)
- Electrolyte imbalance
- Acute renal failure
- Cardiovascular collapse
What to Do:
Treatment is supportive. Monitor vital signs, fluid and electrolyte balance. Hemodialysis can be used to remove iopamidol from the body if necessary, especially in patients with renal failure. Call 1-800-222-1222 (Poison Control) for specific guidance.
Drug Interactions
Major Interactions
- Metformin (in patients with renal impairment or acute kidney injury): Increased risk of lactic acidosis. Metformin should be withheld at the time of or prior to the contrast procedure and for 48 hours afterward, and reinstituted only after renal function has been re-evaluated and found to be normal.
- Interleukin-2 (IL-2): Increased risk of delayed, severe, or protracted contrast reactions (e.g., fever, rash, flu-like symptoms, hypotension, oliguria).
Moderate Interactions
- Beta-blockers: May blunt the compensatory cardiovascular responses to contrast media-induced hypotension or anaphylaxis, making treatment more difficult.
- Diuretics: May increase the risk of contrast-induced nephropathy due to dehydration.
- Nephrotoxic drugs (e.g., NSAIDs, aminoglycosides): Concomitant use may increase the risk of contrast-induced nephropathy.
Confidence Interactions
Monitoring
Baseline Monitoring
Rationale: To assess risk of contrast-induced nephropathy (CIN) and guide metformin management.
Timing: Prior to administration, especially in patients with risk factors for CIN.
Rationale: To identify patients at increased risk for hypersensitivity reactions and determine need for premedication.
Timing: Prior to administration.
Rationale: Adequate hydration helps reduce the risk of CIN.
Timing: Prior to administration.
Routine Monitoring
Frequency: Before, during, and immediately after injection, then periodically for 30-60 minutes post-injection.
Target: Within patient's normal range
Action Threshold: Significant deviations (e.g., hypotension, bradycardia, tachycardia, respiratory distress) require immediate intervention.
Frequency: Continuously during and for at least 30-60 minutes post-injection.
Target: Absence of symptoms
Action Threshold: Any signs of reaction require immediate medical attention and treatment.
Frequency: During and immediately after injection.
Target: Absence of swelling, pain, redness
Action Threshold: Signs of extravasation require immediate cessation of injection and local management.
Symptom Monitoring
- Rash
- Urticaria (hives)
- Pruritus (itching)
- Dyspnea (shortness of breath)
- Wheezing
- Cough
- Angioedema (swelling of face, lips, tongue)
- Hypotension
- Bradycardia
- Tachycardia
- Nausea
- Vomiting
- Headache
- Dizziness
- Flushing
- Chills
- Fever (especially delayed reactions)
- Pain or swelling at injection site
Special Patient Groups
Pregnancy
Category B. Animal reproduction studies have shown no evidence of fetal harm. However, there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed and the potential benefit justifies the potential risk to the fetus. The fetus is exposed to iodine, which could potentially affect thyroid function.
Trimester-Specific Risks:
Lactation
Iopamidol is excreted in human milk in very small amounts (less than 0.5% of the administered dose). Due to minimal absorption from the infant's gastrointestinal tract, adverse effects on the breastfed infant are considered unlikely. Most guidelines suggest that breastfeeding can be continued without interruption or with a brief interruption (e.g., 12-24 hours) if the mother prefers.
Pediatric Use
Dosing is weight-based and procedure-specific. Pediatric patients, especially neonates and infants, may be more susceptible to fluid shifts, electrolyte imbalances, and temperature changes. Careful monitoring of hydration status and vital signs is crucial. Risk of contrast-induced nephropathy should be considered, especially in those with pre-existing renal impairment.
Geriatric Use
Elderly patients are more likely to have pre-existing renal impairment, cardiovascular disease, and diabetes, increasing their risk for adverse reactions such as contrast-induced nephropathy and hypersensitivity reactions. Careful assessment of renal function and hydration status is essential. Use the lowest effective dose.
Clinical Information
Clinical Pearls
- Always ensure adequate hydration before and after contrast administration, especially in patients at risk for contrast-induced nephropathy.
- Premedication with corticosteroids and/or antihistamines may be considered for patients with a history of prior contrast reaction or other significant allergies, though it does not guarantee prevention of reactions.
- Have emergency equipment and medications (e.g., epinephrine, antihistamines, corticosteroids, oxygen) readily available for immediate treatment of hypersensitivity reactions.
- Carefully check patient's medication list for metformin and manage according to institutional protocols.
- Educate patients about potential delayed reactions (e.g., skin rash, flu-like symptoms) that can occur hours to days after administration.
Alternative Therapies
- Iohexol (Omnipaque)
- Iopromide (Ultravist)
- Ioversol (Optiray)
- Iodixanol (Visipaque - iso-osmolar contrast media, potentially lower risk of CIN in high-risk patients)